P40 RR024928/RR/NCRR NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2010	3
2011	5
2012	5
2013	1
2014	1
2020	1
2021	1
2024	0

1

Design and Potential of Non-Integrating Lentiviral Vectors.

Shaw A, Cornetta K. Shaw A, et al. Biomedicines. 2014 Jan 27;2(1):14-35. doi: 10.3390/biomedicines2010014. Biomedicines. 2014. PMID: 28548058 Free PMC article. Review.

2

The National Gene Vector Biorepository: Eleven Years of Providing Resources to the Gene Therapy Community.

Cornetta K, Matheson L, Long R, Duffy L. Cornetta K, et al. Hum Gene Ther. 2020 Feb;31(3-4):145-150. doi: 10.1089/hum.2019.317. Epub 2020 Jan 30. Hum Gene Ther. 2020. PMID: 31910049 Free PMC article. Review.

3

Identifying viral integration sites using SeqMap 2.0.

Hawkins TB, Dantzer J, Peters B, Dinauer M, Mockaitis K, Mooney S, Cornetta K. Hawkins TB, et al. Bioinformatics. 2011 Mar 1;27(5):720-2. doi: 10.1093/bioinformatics/btq722. Epub 2011 Jan 17. Bioinformatics. 2011. PMID: 21245052 Free PMC article.

4

Developing novel lentiviral vectors into clinical products.

Leath A, Cornetta K. Leath A, et al. Methods Enzymol. 2012;507:89-108. doi: 10.1016/B978-0-12-386509-0.00005-3. Methods Enzymol. 2012. PMID: 22365770

5

Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency.

Reinhardt B, Habib O, Shaw KL, Garabedian E, Carbonaro-Sarracino DA, Terrazas D, Fernandez BC, De Oliveira S, Moore TB, Ikeda AK, Engel BC, Podsakoff GM, Hollis RP, Fernandes A, Jackson C, Shupien S, Mishra S, Davila A, Mottahedeh J, Vitomirov A, Meng W, Rosenfeld AM, Roche AM, Hokama P, Reddy S, Everett J, Wang X, Luning Prak ET, Cornetta K, Hershfield MS, Sokolic R, De Ravin SS, Malech HL, Bushman FD, Candotti F, Kohn DB. Reinhardt B, et al. Blood. 2021 Oct 14;138(15):1304-1316. doi: 10.1182/blood.2020010260. Blood. 2021. PMID: 33974038 Free PMC article. Clinical Trial.

6

Replication-competent lentivirus analysis of clinical grade vector products.

Cornetta K, Yao J, Jasti A, Koop S, Douglas M, Hsu D, Couture LA, Hawkins T, Duffy L. Cornetta K, et al. Mol Ther. 2011 Mar;19(3):557-66. doi: 10.1038/mt.2010.278. Epub 2010 Dec 21. Mol Ther. 2011. PMID: 21179010 Free PMC article.

7

Flexibility in cell targeting by pseudotyping lentiviral vectors.

Bischof D, Cornetta K. Bischof D, et al. Methods Mol Biol. 2010;614:53-68. doi: 10.1007/978-1-60761-533-0_3. Methods Mol Biol. 2010. PMID: 20225035

8

Using Pulmozyme DNase treatment in lentiviral vector production.

Shaw A, Bischof D, Jasti A, Ernstberger A, Hawkins T, Cornetta K. Shaw A, et al. Hum Gene Ther Methods. 2012 Feb;23(1):65-71. doi: 10.1089/hgtb.2011.204. Hum Gene Ther Methods. 2012. PMID: 22428981 Free PMC article.

9

A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay.

Aloia AL, Duffy L, Pak V, Lee KE, Sanchez-Martinez S, Derse D, Heidecker G, Cornetta K, Rein A. Aloia AL, et al. Gene Ther. 2013 Feb;20(2):169-76. doi: 10.1038/gt.2012.18. Epub 2012 Mar 8. Gene Ther. 2013. PMID: 22402321 Free PMC article.

10

A simple and effective method to generate lentiviral vectors for ex vivo gene delivery to mature human peripheral blood lymphocytes.

Yang S, Karne NK, Goff SL, Black MA, Xu H, Bischof D, Cornetta K, Rosenberg SA, Morgan RA, Feldman SA. Yang S, et al. Hum Gene Ther Methods. 2012 Apr;23(2):73-83. doi: 10.1089/hgtb.2011.199. Epub 2012 Apr 19. Hum Gene Ther Methods. 2012. PMID: 22515320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year